Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Taneja, Navin ^a,b   Coy, Platina E ^a,b   Lee, Iris ^a,b   Bryson, Jane M ^a,b   Robey, R Brooks ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glucose; Inflammation; Metabolism; Mitogen activated protein kinase; Ras

Indexed keywords

CYTOKINE; HEXOKINASE; HEXOKINASE 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; RAS PROTEIN; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ARTICLE; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; INFLAMMATION; INJURY; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; GLUCOSE; HEXOKINASE; INTERLEUKIN-1; ISOENZYMES; MAP KINASE SIGNALING SYSTEM; MICE; PROTEIN KINASE C; RECEPTORS, INTERLEUKIN-1;

ANIMALIA;

EID: 3242729483     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00126.2003     Document Type: Article

References (72)

1. Ahmad A, Ahmad S, Schneider BK, Allen CB, Chang LY, and White CW. Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. Am J Physiol Lung Cell Mol Physiol 283: L573-L584, 2002.
2. Allen CB, Guo XL, and White CW. Changes in pulmonary expression of hexokinase and glucose transporter mRNAs in rats adapted to hyperoxia. Am J Physiol Lung Cell Mol Physiol 274: L320-L329, 1998.
3. Anderson JW and Stowring L. Glycolytic and gluconeogenic enzyme activities in renal cortex of diabetic rats. Am J Physiol 224: 930-936, 1973.
4. Azoulay-Zohar H, Israelson A, Abu-Hamad S, and Shoshan-Barmatz V. In self-defense: hexokinase promotes VDAC closure and prevents mitochondria- mediated apoptotic cell death. Biochem J 377: 347-355, 2004.
5. Becker TC, Noel RJ, Coats WS, Gómez-Foix AM, Alam T, Gerard RD, and Newgard CB. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43: 161-189, 1994.
6. Ben-Shlomo I, Kol S, Roeder LM, Resnick CE, Hurwitz A, Payne DW, and Adashi EY. Interleukin (IL)-1β increases glucose uptake and induces glycolysis in aerobically cultured rat ovarian cells: evidence that IL-1β may mediate the gonadotropin-induced midcycle metabolic shift. Endocrinology 138: 2680-2688, 1997.
7. Bensen JT, Langefeld CD, Li L, McCall CE, Cousart SL, Dryman BN, Freedman BI, and Bowden DW. Association of an IL-IA 3′UTR polymorphism with end-stage renal disease and IL-1α expression. Kidney Int 63: 1211-1219, 2003.
8. 2-adrenergic receptor expression in human airway epithelial cells by activating PKC. Am J Physiol Lung Cell Mol Physiol 280: L675-L679, 2001.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Bryson JM, Coy PE, Gottlob K, Hay N, and Robey RB. Increased hexokinase expression, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 277: 11392-11400, 2002.
11. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, Endres S, Lonnesmann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, and Dinarello CA. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever, J Infect Dis 161: 79-84, 1990.
12. Casey LC, Balk RA, and Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771-778, 1993.
13. 12 muscle cells is independent of PKC-α, -ε, and -θ. Am J Physiol Endocrinol Metab 282: E1204-E1213, 2002.
14. Coy PE, Taneja N, Lee I, Hecquet C, Bryson JM, and Robey RB. LPA is a novel lipid regulator of hexokinase activity and HKII isoform expression in mesangial cells. Am J Physiol Renal Physiol 283: F271-F279, 2002.
15. Diamond JR, Ding G, Frye J, and Diamond IP. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome. Am J Pathol 141: 887-894, 1992.
16. Dinarello CA. Interleukin-1. In: The Cytokine Handbook (3rd ed.), edited by Thomson AW. San Diego, CA: Academic, 1998, p. 35-72.
17. Dinarello CA and Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12: 404-410, 1991.
18. Dripps DJ, Brandhuber BJ, Thompson RC, and Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa 1L-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266: 10331-10336, 1991.
19. Dubach UC and Recant L. Enzymatic activity of the isolated glomerulus in normal and nephrotic rats. J Clin Invest 39: 1364-1371, 1960.
20. Durum SK, Schmidt JA, and Oppenheim JJ. Interleukin 1: an immunological perspective. Annu Rev Immunol 3: 263-287, 1985.
21. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, and Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341-346, 1990.
22. 2+. Am J Physiol Renal Fluid Electrolyte Physiol 259: F269-F278, 1990.
23. asn17 in 3T3L1 adipocytes does not alter insulin-stimulated PI3-kinase activity or glucose transport. Mol Endocrinol 11: 67-76, 1997.
24. Godbole A, Varghese J, Sarin A, and Mathew MK. VDAC is a conserved element of death pathways in plant and animal systems. Biochim Biophys Acta 1642: 87-96, 2003.
25. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, and Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418, 2001.
26. Gould GW, Cuenda A, Thomson FJ, and Cohen PJ. The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. Biochem J 311: 735-738, 1995.
27. Grossbard L and Schimke RT. Multiple hexokinases of rat tissues: purification and comparison of soluble forms. J Biol Chem 241: 3546-3560, 1966.
28. 2+ fluctuations in L6 myotubes in the regulations of the hexokinase II gene. J Appl Physiol 88: 669-673, 2000.
29. Hernvann A, Bourely B, Le Maire V, Aussel C, Menkes CJ, and Ekindjian OG. Action of anti-inflammatory drugs on interleukin-1β-mediated glucose uptake by synoviocytes. Eur J Pharmacol 314: 193-196, 1996.
30. Hernvann A, Jaffray P, Hilliquin P, Cazalet C, Menkes CJ, and Ekindjian OG. Interleukin-1β-mediated glucose uptake by chondrocytes. Inhibition by cortisol. Osteoarthritis Cartilage 4: 139-142, 1996.
31. Huwiler A and Pfeilschifter J. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett 350: 135-138, 1994.
32. Kolomytkin OV, Marino AA, Sadasivan KK, Wolf RE, and Albright JA. Intracellular signaling mechanisms of interleukin-1β in synovial fibroblasts. Am J Physiol Cell Physiol 276: C9-C15, 1999.
33. Kruse M, Mahiout A, Kliem V, Kurz P, Koch KM, and Brunkhorst R. Interleukin-1β stimulates glucose uptake of human peritoneal mesothelial cells in vitro. Perit Dial Int 16, Suppl 1: S58-S60, 1996.
34. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, and Molkentin JD. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460-7469, 2001.
35. Lin CH, Sheu SY, Lee HM, Ho YS, Lee WS, Ko WC, and Sheu JR. Involvement of protein kinase C-γ in IL-1β-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Mol Pharmacol 57: 36-43, 2000.
36. Lovett DH and Larsen A. Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. J Clin Invest 82: 115-122, 1988.
37. Lovett DH, Ryan JL, and Sterzel RB. Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immunol 131: 2830-2836, 1983.
38. Lovett DH, Szamel M, Ryan JL, Sterzel RB, Gemsa D, and Resch K. Interleukin I and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol 136: 3700-3705, 1986.
39. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, and Striker GE. Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 33: 677-684, 1988.
40. Magil AB and Frohlich JJ. Monocytes and macrophages in focal glomerulosclerosis in Zucker rats. Nephron 59: 131-138, 1991.
41. Maile S, Zimmerman B, Ketteler M, and Merker HJ. The morphology of mesangial cells cultured at high density and in collagen gels. Histol Histopathol 15: 403-414, 2000.
42. Majewski N, Nogueira V, Robey RB, and Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 24: 730-740, 2004.
43. Mené P, Simonson MS, and Dunn MJ. Physiology of the mesangial cell. Physiol Rev 69: 1347-1424, 1989.
44. Muñoz E, Beutner U, Zubiaga A, and Huber BT. IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 144: 964-969, 1990.
45. O'Neill LAJ. Towards an understanding of the signal transduction pathways for interleukin 1. Biochim Biophys Acta 1266: 31-44, 1995.
46. O'Neill LAJ, Bird TA, and Saklatvala J. Interleukin 1 signal transduction. Immunol Today 11: 392-394, 1990.
47. Oppenheim JJ, Kovacs EJ, Matsushima K, and Durum SK. There is more than one interleukin 1. Immunol Today 7: 45-56, 1986.
48. Osawa H, Printz RL, Whitesell RR, and Granner DK. Regulation of hexokinase II gene transcription and glucose phosphorylation by catecholamines, cyclic AMP, and insulin. Diabetes 44: 1426-1432, 1995.
49. Osawa H, Sutherland C, Robey RB, Printz RL, and Granner DK. Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin. J Biol Chem 271: 16690-16694, 1996.
50. Pastorino JG, Shulga N, and Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277: 7610-7618, 2002.
51. Pfeilschifter J, Pignat W, Vosbeck K, and Märki F. Interleukin 1 and tumour necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun 159: 385-394, 1989.
52. 2 by rat mesangial cells: its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92: 2516-2523, 1993.
53. Robey RB, Ma J, and Santos AVP. Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway. Am J Physiol Renal Physiol 277: F742-F749, 1999.
54. Robey RB, Ma J, Santos AVP, Noboa OA, Coy PE, and Bryson JM. Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression. J Biol Chem 277: 14370-14378, 2002.
55. Robey RB, Raval BJ, Ma J, and Santos AVP. Thrombin is a novel regulator of hexokinase activity in mesangial cells. Kidney Int 57: 2308-2318, 2000.
56. Ruan XZ, Varghese Z, Fernando R, and Moorhead JF. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 13: 1391-1397, 1998.
57. Rzymkiewicz DM, DuMaine J, and Morrison AR. IL-1β regulates rat mesangial cyclooxygenase II gene expression by tyrosine phosphorylation. Kidney Int 47: 1354-1363, 1995.
58. 2 in rat mesangial cells. Biochem Biophys Res Commun 174: 268-275, 1991.
59. Sochor M, Kunjara S, and McLean P. Regulation of pathways of glucose metabolism in the kidney. The activity of the pentose phosphate pathway, glycolytic route and the regulation of phosphofructokinase in the kidney of lean and genetically obese (ob/ob) mice; comparison with effects of diabetes. Horm Metab Res 20: 676-681, 1988.
60. Steer KA, Sochor M, Gonzalez AM, and McLean P. Regulation of pathways of glucose metabolism in kidney: specific linking of pentose phosphate pathway activity with kidney growth in experimental diabetes and unilateral nephrectomy. FEBS Lett 150: 494-498, 1982.
61. Tateyama F, Yamabe H, Osawa H, Kaizuka M, Shirato K, and Okumura K. Interleukin-1β is an autocrine growth factor of rat glomerular epithelial cells in culture. Nephrol Dial Transplant 16: 1149-1155, 2001.
62. 2 in endothelial cells. Am J Physiol Heart Circ Physiol 276: H1493-H1501, 1999.
63. Tesch GH, Lan HY, Atkins RC, and Nikolic-Paterson DJ. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol 151: 141-150, 1997.
64. Van Goor H, van der Horst MLC, Fidler V, and Grond J. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest 66: 564-571, 1992.
65. Werber HI, Emancipator SN, Tykocinski ML, and Sedor JR. The interleukin I gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol 138: 3207-3212, 1987.
66. White CW, Ghezzi P, Dinarello CA, Caldwell SA, McMurtry IF, and Repine JE. Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J Clin Invest 79: 1868-1873, 1987.
67. Wilmer WA, Tan LC, Dickerson JA, Danne M, and Rovin BH. Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells: role of oxidation. J Biol Chem 272: 10877-10881, 1997.
68. 2+ mobilization in canine tracheal smooth-muscle cells: Involvement of the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway. Biochem J 354: 439-446, 2001.
69. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, and Couser WG. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995.
70. 2. Mol Pharmacol 48: 550-558, 1995.
71. Zoja C, Bettoni S, Morigi M, Remuzzi G, and Rambaldi A. Interleukin-1 regulates cytokine gene expression in human mesangial cells through the interleukin-1 receptor type 1. J Am Soc Nephrol 2: 1709-1715, 1992.
72. Zoja C, Rambaldi A, and Remuzzi G. Interleukin-1 and glomerular mesangial cells. Renal Physiol Biochem 16: 89-92, 1993.